Učitavanje...
CA2-05: Continuous Monitoring and Timely Intervention are Needed to Improve Adherence to Adjuvant Hormonal Therapy Among Breast Cancer Patients
BACKGROUND/AIMS: There are approximately 150,000 new hormone-sensitive breast cancer cases in the U.S. each year. Numerous studies have shown that adjuvant hormonal therapy (AHT) dramatically reduces breast cancer recurrence and mortality. Daily treatment for 5 years is the recommended therapy among...
Spremljeno u:
| Glavni autori: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Marshfield Clinic
2012
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3421386/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.2012.1100.ca2-05 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|